Patients should examine injection sites for lumps, indentations, redness, or tenderness
Skipping a single dose does not reverse previous weight loss, but it may interrupt the behavioral momentum you've built and increase the risk of dietary lapses during that week
Weight loss was a side effect (or benefit) seen in clinical trials, so semaglutide was subsequently repackaged as a weight-loss drug (with the brand name Wegovy)
Registered studies evaluating Retatrutide in obesity, overweight, type 2 diabetes, and related metabolic conditions
Our primary outcome was glycemic control as measured by the change in HbA1C from baseline to end of study
Patients with kidney disease, history of kidney stones, or metabolic disorders require especially careful monitoring